Fetal antiepileptic drug exposure

Adaptive and emotional/behavioral functioning at age 6years

Morris J. Cohen, Kimford J. Meador, Nancy Browning, Ryan May, Gus A. Baker, Jill Clayton-Smith, Laura A. Kalayjian, Andres M Kanner, Joyce D. Liporace, Page B. Pennell, Michael Privitera, David W. Loring

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study is a prospective observational multicenter study in the USA and UK, which enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study aimed to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, and valproate). In this report, we examine fetal AED exposure effects on adaptive and emotional/behavioral functioning at 6. years of age in 195 children (including three sets of twins) whose parent (in most cases, the mother) completed at least one of the rating scales. Adjusted mean scores for the four AED groups were in the low average to average range for parent ratings of adaptive functioning on the Adaptive Behavior Assessment System-Second Edition (ABAS-II) and for parent and teacher ratings of emotional/behavioral functioning on the Behavior Assessment System for Children (BASC). However, children whose mothers took valproate during pregnancy had significantly lower General Adaptive Composite scores than the lamotrigine and phenytoin groups. Further, a significant dose-related performance decline in parental ratings of adaptive functioning was seen for both valproate and phenytoin. Children whose mothers took valproate were also rated by their parents as exhibiting significantly more atypical behaviors and inattention than those in the lamotrigine and phenytoin groups. Based upon BASC parent and teacher ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy were at a significantly greater risk for a diagnosis of ADHD. The increased likelihood of difficulty with adaptive functioning and ADHD with fetal valproate exposure should be communicated to women with epilepsy who require antiepileptic medication. Finally, additional research is needed to confirm these findings in larger prospective study samples, examine potential risks associated with other AEDs, better define the risks to the neonate that are associated with AEDs for treatment of seizures, and understand the underlying mechanisms of adverse AED effects on the immature brain.

Original languageEnglish (US)
Pages (from-to)308-315
Number of pages8
JournalEpilepsy and Behavior
Volume29
Issue number2
DOIs
StatePublished - Nov 2013
Externally publishedYes

Fingerprint

Valproic Acid
Anticonvulsants
Phenytoin
Mothers
Epilepsy
Pregnancy
Psychological Adaptation
Carbamazepine
Multicenter Studies
Observational Studies
Pregnant Women
Seizures
Parents
Newborn Infant
Prospective Studies
Brain
Research
lamotrigine

Keywords

  • Antiepileptic drugs
  • Behavioral neurology
  • Child development
  • Epilepsy
  • Pregnancy
  • Valproate

ASJC Scopus subject areas

  • Clinical Neurology
  • Behavioral Neuroscience
  • Neurology

Cite this

Cohen, M. J., Meador, K. J., Browning, N., May, R., Baker, G. A., Clayton-Smith, J., ... Loring, D. W. (2013). Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years. Epilepsy and Behavior, 29(2), 308-315. https://doi.org/10.1016/j.yebeh.2013.08.001

Fetal antiepileptic drug exposure : Adaptive and emotional/behavioral functioning at age 6years. / Cohen, Morris J.; Meador, Kimford J.; Browning, Nancy; May, Ryan; Baker, Gus A.; Clayton-Smith, Jill; Kalayjian, Laura A.; Kanner, Andres M; Liporace, Joyce D.; Pennell, Page B.; Privitera, Michael; Loring, David W.

In: Epilepsy and Behavior, Vol. 29, No. 2, 11.2013, p. 308-315.

Research output: Contribution to journalArticle

Cohen, MJ, Meador, KJ, Browning, N, May, R, Baker, GA, Clayton-Smith, J, Kalayjian, LA, Kanner, AM, Liporace, JD, Pennell, PB, Privitera, M & Loring, DW 2013, 'Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years', Epilepsy and Behavior, vol. 29, no. 2, pp. 308-315. https://doi.org/10.1016/j.yebeh.2013.08.001
Cohen, Morris J. ; Meador, Kimford J. ; Browning, Nancy ; May, Ryan ; Baker, Gus A. ; Clayton-Smith, Jill ; Kalayjian, Laura A. ; Kanner, Andres M ; Liporace, Joyce D. ; Pennell, Page B. ; Privitera, Michael ; Loring, David W. / Fetal antiepileptic drug exposure : Adaptive and emotional/behavioral functioning at age 6years. In: Epilepsy and Behavior. 2013 ; Vol. 29, No. 2. pp. 308-315.
@article{c8528b43a03d40b2af97ae4e92b1ac0c,
title = "Fetal antiepileptic drug exposure: Adaptive and emotional/behavioral functioning at age 6years",
abstract = "The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study is a prospective observational multicenter study in the USA and UK, which enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study aimed to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, and valproate). In this report, we examine fetal AED exposure effects on adaptive and emotional/behavioral functioning at 6. years of age in 195 children (including three sets of twins) whose parent (in most cases, the mother) completed at least one of the rating scales. Adjusted mean scores for the four AED groups were in the low average to average range for parent ratings of adaptive functioning on the Adaptive Behavior Assessment System-Second Edition (ABAS-II) and for parent and teacher ratings of emotional/behavioral functioning on the Behavior Assessment System for Children (BASC). However, children whose mothers took valproate during pregnancy had significantly lower General Adaptive Composite scores than the lamotrigine and phenytoin groups. Further, a significant dose-related performance decline in parental ratings of adaptive functioning was seen for both valproate and phenytoin. Children whose mothers took valproate were also rated by their parents as exhibiting significantly more atypical behaviors and inattention than those in the lamotrigine and phenytoin groups. Based upon BASC parent and teacher ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy were at a significantly greater risk for a diagnosis of ADHD. The increased likelihood of difficulty with adaptive functioning and ADHD with fetal valproate exposure should be communicated to women with epilepsy who require antiepileptic medication. Finally, additional research is needed to confirm these findings in larger prospective study samples, examine potential risks associated with other AEDs, better define the risks to the neonate that are associated with AEDs for treatment of seizures, and understand the underlying mechanisms of adverse AED effects on the immature brain.",
keywords = "Antiepileptic drugs, Behavioral neurology, Child development, Epilepsy, Pregnancy, Valproate",
author = "Cohen, {Morris J.} and Meador, {Kimford J.} and Nancy Browning and Ryan May and Baker, {Gus A.} and Jill Clayton-Smith and Kalayjian, {Laura A.} and Kanner, {Andres M} and Liporace, {Joyce D.} and Pennell, {Page B.} and Michael Privitera and Loring, {David W.}",
year = "2013",
month = "11",
doi = "10.1016/j.yebeh.2013.08.001",
language = "English (US)",
volume = "29",
pages = "308--315",
journal = "Epilepsy and Behavior",
issn = "1525-5050",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Fetal antiepileptic drug exposure

T2 - Adaptive and emotional/behavioral functioning at age 6years

AU - Cohen, Morris J.

AU - Meador, Kimford J.

AU - Browning, Nancy

AU - May, Ryan

AU - Baker, Gus A.

AU - Clayton-Smith, Jill

AU - Kalayjian, Laura A.

AU - Kanner, Andres M

AU - Liporace, Joyce D.

AU - Pennell, Page B.

AU - Privitera, Michael

AU - Loring, David W.

PY - 2013/11

Y1 - 2013/11

N2 - The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study is a prospective observational multicenter study in the USA and UK, which enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study aimed to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, and valproate). In this report, we examine fetal AED exposure effects on adaptive and emotional/behavioral functioning at 6. years of age in 195 children (including three sets of twins) whose parent (in most cases, the mother) completed at least one of the rating scales. Adjusted mean scores for the four AED groups were in the low average to average range for parent ratings of adaptive functioning on the Adaptive Behavior Assessment System-Second Edition (ABAS-II) and for parent and teacher ratings of emotional/behavioral functioning on the Behavior Assessment System for Children (BASC). However, children whose mothers took valproate during pregnancy had significantly lower General Adaptive Composite scores than the lamotrigine and phenytoin groups. Further, a significant dose-related performance decline in parental ratings of adaptive functioning was seen for both valproate and phenytoin. Children whose mothers took valproate were also rated by their parents as exhibiting significantly more atypical behaviors and inattention than those in the lamotrigine and phenytoin groups. Based upon BASC parent and teacher ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy were at a significantly greater risk for a diagnosis of ADHD. The increased likelihood of difficulty with adaptive functioning and ADHD with fetal valproate exposure should be communicated to women with epilepsy who require antiepileptic medication. Finally, additional research is needed to confirm these findings in larger prospective study samples, examine potential risks associated with other AEDs, better define the risks to the neonate that are associated with AEDs for treatment of seizures, and understand the underlying mechanisms of adverse AED effects on the immature brain.

AB - The Neurodevelopmental Effects of Antiepileptic Drugs (NEAD) study is a prospective observational multicenter study in the USA and UK, which enrolled pregnant women with epilepsy on antiepileptic drug (AED) monotherapy from 1999 to 2004. The study aimed to determine if differential long-term neurodevelopmental effects exist across four commonly used AEDs (carbamazepine, lamotrigine, phenytoin, and valproate). In this report, we examine fetal AED exposure effects on adaptive and emotional/behavioral functioning at 6. years of age in 195 children (including three sets of twins) whose parent (in most cases, the mother) completed at least one of the rating scales. Adjusted mean scores for the four AED groups were in the low average to average range for parent ratings of adaptive functioning on the Adaptive Behavior Assessment System-Second Edition (ABAS-II) and for parent and teacher ratings of emotional/behavioral functioning on the Behavior Assessment System for Children (BASC). However, children whose mothers took valproate during pregnancy had significantly lower General Adaptive Composite scores than the lamotrigine and phenytoin groups. Further, a significant dose-related performance decline in parental ratings of adaptive functioning was seen for both valproate and phenytoin. Children whose mothers took valproate were also rated by their parents as exhibiting significantly more atypical behaviors and inattention than those in the lamotrigine and phenytoin groups. Based upon BASC parent and teacher ratings of attention span and hyperactivity, children of mothers who took valproate during their pregnancy were at a significantly greater risk for a diagnosis of ADHD. The increased likelihood of difficulty with adaptive functioning and ADHD with fetal valproate exposure should be communicated to women with epilepsy who require antiepileptic medication. Finally, additional research is needed to confirm these findings in larger prospective study samples, examine potential risks associated with other AEDs, better define the risks to the neonate that are associated with AEDs for treatment of seizures, and understand the underlying mechanisms of adverse AED effects on the immature brain.

KW - Antiepileptic drugs

KW - Behavioral neurology

KW - Child development

KW - Epilepsy

KW - Pregnancy

KW - Valproate

UR - http://www.scopus.com/inward/record.url?scp=84885078166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885078166&partnerID=8YFLogxK

U2 - 10.1016/j.yebeh.2013.08.001

DO - 10.1016/j.yebeh.2013.08.001

M3 - Article

VL - 29

SP - 308

EP - 315

JO - Epilepsy and Behavior

JF - Epilepsy and Behavior

SN - 1525-5050

IS - 2

ER -